A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks.

Starting soon · Phase 2/Phase 3

Conditions studied: Acne

In brief

This study is conducted to check how well the Dermapen 4™ microneedling device works with MG-CLR serum for treating acne over 12 weeks.

Key facts

Study ID

NCT06602284

Run by

Equipmed USA LLC

People needed

10

Starts

2024-10-01

Expected to finish

2025-03-01

Last updated by the study team

2024-09-19

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female subjects aged between 18-45 years (both ages inclusive)
• Fitzpatrick skin phototype I to VI.
• Subjects having IGA score of 2 and 3.
• Subjects who have not received any kind of treatment for acne 1 month before the start of the study.
• Subject free of excessive hair, cuts, abrasions, fissures, wounds, lacerations, or any other skin conditions on the face.
• Subjects who agree not to use any other product/treatment/home remedy/ except the provided products on their face during the study period

You may not qualify if…

• Subjects with known skin condition that may impact the assessment.
• Subjects with active Herpes labialis infection.
• Subjects known to have bleeding and clotting disorders (self-declared).
• Subjects known to have connective tissue disorders.
• Subjects with any other signs of significant local irritation or skin disease.
• Subjects currently taking any medication, which the investigator believes may influence the interpretation of the data.

Where it is running

• Skin Wellness Dermatology — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.